ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,557Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 6969

$2.69M Total Retail Price of All Prescriptions

Rank: 13 out of 6969

469 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 14,906 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

80% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$163 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LOVAZA 1,020 889 1 77
CRESTOR 811 723 2 39
CELEBREX 590 514 3 67
BENICAR 589 543 4 107
ATELVIA 457 405 5 111
DEXILANT 446 401 6 110
EFFIENT 441 382 10 7 272
FLECTOR 381 348 10 8 264
PATADAY 313 293 9 213
LIDODERM 274 239 10 75
WELCHOL 272 211 11 235
AZOR 245 208 12 233
BENICAR HCT 228 222 13 176
RANEXA 219 212 14 357
NAMENDA 208 198 15 51
ZOLPIDEM TARTRATE 204 187 16 16
AMOXICILLIN 203 193 17 99
LYRICA 200 177 18 137
BYSTOLIC 195 181 19 155
RAPAFLO 186 185 20 347
TRIBENZOR 175 136 21 359
NIASPAN 171 114 22 146
ULORIC 150 136 23 243
ACIPHEX 147 126 24 181
ENABLEX 142 126 25 299
TRIAMCINOLONE ACETONIDE 140 138 26 55
VOLTAREN 137 135 27 105
AVODART 137 136 27 108
BONIVA 132 129 29 198
FLUOCINONIDE 130 123 30 134
AMITIZA 128 106 31 254
ACTONEL 120 112 32 115
NASONEX 120 118 32 144
TRILIPIX 119 106 34 175
SPIRIVA 114 103 35 66
COREG CR 111 98 36 252
VIMOVO 111 104 10 36 404
ONGLYZA 109 108 38 164
LIVALO 108 108 39 332
CYCLOBENZAPRINE HCL 100 73 R 40 130
ARICEPT 98 98 41 399
DALIRESP 98 91 41 454
CREON 95 95 43 147
ATORVASTATIN CALCIUM 95 86 43 11
SINGULAIR 93 92 45 84
AZITHROMYCIN 90 83 46 42
MEGACE ES 88 87 R 47 442
KOMBIGLYZE XR 87 62 48 312
ACTOPLUS MET 85 83 49 266
AMLODIPINE BESYLATE 85 82 49 4
PROCTOZONE-HC 82 81 51 293
NEXIUM 82 75 51 52
VIREAD 78 77 53 288
SYMBICORT 78 64 53 149
ADVAIR DISKUS 77 76 55 45
BETAMETHASONE DIPROPIONATE 77 77 55 250
FUROSEMIDE 74 71 57 10
AVELOX 72 67 58 545
MECLIZINE HCL 72 71 58 100
TRADJENTA 70 69 60 325
DIPHENOXYLATE-ATROPINE 69 64 61 214
EDARBI 69 69 10 61 477
ACTOS 68 47 63 61
METFORMIN HCL 68 59 63 7
EXELON 64 64 65 157
OMEPRAZOLE 63 59 66 6
EDARBYCLOR 59 59 10 67 570
DIOVAN 59 57 67 26
METOPROLOL SUCCINATE 59 44 67 22
PRADAXA 59 59 67 313
SIMVASTATIN 58 54 71 1
NIFEDIPINE ER 57 45 72 95
AGGRENOX 56 46 73 270
ACETAMINOPHEN-CODEINE 56 52 S3 73 73
BARACLUDE 55 44 75 490
PATANOL 55 50 75 142
RESTASIS 55 52 75 354
MELOXICAM 53 40 78 36
HYDROCODONE-ACETAMINOPHEN 51 39 S3 79 3
METOCLOPRAMIDE HCL 51 42 79 136
LOSARTAN POTASSIUM 51 46 79 12
DONEPEZIL HCL 50 28 82 32
HYDROXYZINE HCL 50 49 R 82 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.